Makoto KINOSHITA 兄妹交配 特記 : ヘテロ型×ヘテロ型もしくは野生型 注）Sept4-/-は雄性不妊 形態の異常・奇形がある 繁殖成績が低い C (3-6 months) Sept4 null homozygous mouse for a septin gene, Sept4. 開発者/機関 : Dr. Makoto Kinoshita/Kyoto University Graduate School of Medicine開発年 : 2005-2007年C57BL/6Jコンジェニック系統。129系統ES細胞を用いて作出。C57BL/6Jに20世代以上戻し交配を行う。その後，兄妹交配にて維持。 RBRC03798 B6.129X1-Sept4<tm1Ksh> B6.129X1-Sept4<tm1Ksh> true The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Dev. Cell., 8, 343-352 (2005).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for publication of research papers. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. Phage P1 loxP sites, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse Sept4 genomic DNA 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Dev. Cell., 8, 343-352 (2005).<br>研究成果の公表にあたって謝辞の表明を必要とする。<br>公表を前提とした学術研究に限る。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。 兄妹交配特記 : ヘテロ型×ヘテロ型もしくは野生型 注）Sept4-/-は雄性不妊形態の異常・奇形がある繁殖成績が低い B6J-Sept4 KO B6J-Sept4 KO Sept4 nullizygous mouse for a septin gene, Sept4 C（3〜6か月） 木下　専 <a href='https://brc.riken.jp/mus/pcr03798'>Genotyping protocol -PCR-</a> Necessary documents for ordering:<ol><li>Approval form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_6.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_d.docx">English</A>)</li><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="https://sites.google.com/site/kinoshitalabnagoya/" target="_blank">Lab HP (Japanese)</A> 開発者/機関 : Dr. Makoto Kinoshita/Kyoto University Graduate School of Medicine 開発年 : 2005-2007年 C57BL/6Jコンジェニック系統。129系統ES細胞を用いて作出。C57BL/6Jに20世代以上戻し交配を行う。その後，兄妹交配にて維持。 Developed by Makoto Kinoshita, Kyoto University Graduate School of Medicine in 2005-2007. Cre/loxP system